Objective: Methods that use claims data to identify patients with aortic dissection (AD) for study are not well validated. We aimed to evaluate the accuracy of previously reported diagnosis and procedural coding mechanisms to identify AD admissions and treatment types for patients with acute AD at our institution.
Methods: All inpatient hospitalizations at a single center between 2000 and 2015 were retrospectively reviewed for an AD diagnosis code (International Classification of Diseases, Ninth Revision and Tenth Revision) through institutional billing databases. Diagnoses were verified using medical records and imaging studies. Characteristics of the aortic disease, treatment modalities, and procedural codes were abstracted. Sensitivity and specificity analyses were performed to test the ability of diagnosis and procedural codes to correctly identify the anatomic involvement of the aorta and treatment type for acute AD (TASR, type A open surgery repair; TBSR, type B open surgery repair; TEVAR, thoracic endovascular repair; MM, medical management).
Results: Diagnosis codes identified 1697 hospitalizations among 1312 patients. AD was present in 1295 (76%) visits. In 281 (17%) visits, no aortic disease was present, and 121 (7%) were for intramural hematoma or penetrating aortic ulcer without AD. Among visits with AD, 438 (34%) were first-time visits for acute AD, 11 (<1%) were readmissions for acute AD, 112 (9%) were for subacute AD, 620 (48%) were for chronic AD, and 114 (9%) were for AD of unknown age. There were 223 (51%) acute AD visits that ranked AD among the top three discharge diagnoses, and 202 (46%) did not rank AD at all. Stanford type A AD was present for 260 (59%) acute visits and Stanford type B for 178 (41%). Acute AD management included 229 (52%) open surgery, 28 (6%) endovascular surgery, 10 (2%) open and endovascular surgery, and 171 (39%) medical. Diagnosis coding demonstrated sensitivities and specificities for aortic involvement as follows: thoracic (sensitivity, 46%; specificity, 75%), thoracoabdominal (sensitivity, 22%; specificity, 98%), and abdominal (sensitivity, 65%; specificity, 98%). Procedural coding had low sensitivities: TASR (sensitivity, 29%; specificity, 98%), TBSR (sensitivity, 0%; specificity, 100%), TEVAR (sensitivity, 9%; specificity, 100%), MM (sensitivity, 46%; specificity, 97%). After exclusion of cases with diagnosis of aneurysm, sensitivities and specificities were minimally changed: TASR (sensitivity, 25%; specificity, 99%), TBSR (sensitivity, 0%; specificity, 100%), TEVAR (sensitivity, 9%; specificity, 100%), and MM (sensitivity, 45%; specificity, 98%).
Conclusions: At our institution, one in four inpatient hospitalizations coded for AD demonstrated no evidence of dissection. Current billing stratification methods to determine type of acute AD and treatment modality have poor sensitivities but are highly specific. To more effectively use claims data to study AD, more sensitive methods are necessary. Objective: The impact of acute aortic syndrome (AAS) on mortality and aorta-related events has not been examined from a population-based approach. This study analyzes aorta-related outcomes in a newly diagnosed cohort of AAS patients.
Methods: Medical records and death certificates of all Olmsted County, Minnesota, residents diagnosed with AAS (aortic dissection [AD] , intramural hematoma [IMH] , and penetrating aortic ulcer [PAU] ) from 1995 to 2015 were reviewed and compared with age-and sex-matched (3:1) population controls. Primary end points were any cause and aortarelated mortality. Secondary end point was time to any subsequent aorta-related event (aortic intervention, new dissection, or rupture). Outcomes were compared using Cox proportional hazards regression.
Results: There were 133 patients with AAS (77 AD, 21 IMH, 35 PAU); 57% were male, median age was 72 years (standard deviation, 14 years), and median follow-up was 10 years. AAS was associated with lower overall survival at 5, 10, and 20 years compared with controls (62%, 44%, and 9% vs 83%, 60%, and 38%; adjusted hazard ratio [HR], 1.8; P ¼ .0004). Aorta-related death occurred in 23 (32%) of 73 AAS decedents because of rupture (12), surgical complications (5), ischemic complications (4), and other aorta-related causes (2). No aortic deaths occurred in controls. Freedom from aorta-related death was 80% and 77% at 10 and 20 years after AAS diagnosis (adjusted HR, 150.1; P ¼ .0006). This was driven by AD (HR, 109.6; P ¼ .002) and IMH (HR, 32.9; P ¼ .037) but not by PAU. Among AAS patients, 50 (38%) had an aortic event after diagnosis (48 interventions, 7 new dissections, 7 ruptures, or combinations), whereas there were 8 aortic events among controls (8 nonruptured aneurysm repairs), resulting in a higher risk of any aorta-related event for AAS cases (HR, 28.5; P < .0001; Fig) and for each subtype. Freedom from aortic intervention was lower for AAS cases at 10 years (59% vs 97%; HR, 26.9; P < .0001) and for each subtype. After exclusion of acute events (14 days of diagnosis), AAS was still associated with a higher risk of overall mortality (adjusted HR, 1.6; P ¼ .011), aorta-related mortality (HR, 73.7; P ¼ .005), any aortic event (HR, 8.8; P < .0001), and aortic intervention (HR, 8.0; P < .0001). PAU individually was not associated with long-term events.
Conclusions: AAS patients have a significantly higher risk of any cause and aorta-related mortality than population controls. After the acute phase, the risk of aortic intervention remains eightfold, primarily in AD and IMH. PAU appears to confer little long-term aorta-related risk. Advances in postdiagnosis treatment are necessary to improve the prognosis in AAS Objective: Using a national data set, we sought to describe the population of patients for and the nature and timing of reinterventions after thoracic endovascular aortic repair (TEVAR) by aortic disease as well as by the impact on survival.
Methods: We evaluated the national data set for TEVAR in the Vascular Quality Initiative from 2010 to 2017. Student t-test and c 2 analysis were used to compare continuous and categorical variables in the reintervention and no reintervention groups, respectively. Freedom from reintervention and survival analysis was performed using Kaplan-Meier methods.
Results: A total of 6170 patients were evaluated: 51.2%, thoracic aortic aneurysm; 33.5%, type B dissection (TBD); 6.7%, trauma; 7.0%, penetrating aortic ulcer; and 1.6%, intramural hematoma. Overall, 477 (7.73%) underwent at least one reintervention, with an in-hospital reintervention rate of 3.29%. Reintervention patients were younger (64.4 6 14.5 vs 66.0 6 14.5 years; P ¼ .022) and more often transferred (37.7% vs 29.6%; P < .001), urgent (41.5% vs 33.6%; P ¼ .01), hypertensive (87.6% vs 83.8%; P ¼ .030), anticoagulated (14.0% vs 10.1%; P ¼ .007), symptomatic (54.3% vs 48.7%; P < .001), and ruptured (10.2% vs 6.5%; P < .001). In addition, the reintervention group exhibited more complexity with greater contrast material volume (130 6 81 vs 113 676 mL; P < .001), estimated blood loss (318 6 606 vs 281 6 517 mL; P ¼ .142), procedure time (183.5 6 128.0 vs 170.4 6 112.7 minutes; P ¼ .016), arm/neck access (28.9% vs 20.3%; P < .001), proximal deployment zones 0 to 2 (41.5% vs 16.9; P < .001), and larger mean proximal graft diameter (36.0 6 4.2 mm vs 34.1 6 5.4 mm; P ¼ .002). The reintervention group had more complicated postoperative courses marked by longer intensive care unit stays (6.5 6 7.4 vs 4.2 6 6.3 days; P < .001), total length of stay (16.1 6 35.0 vs 10.1 6 22.8 days; P < .001), more packed red blood cells (2.1 6 3.8 vs 1.2 6 3.1 units; P < .001), and vasopressor use (35.4% vs 23.8%; P < .001). Reinterventions were most commonly performed for TBD (12.4%), with reinterventions for other diseases occurring at lower rates: thoracic aortic aneurysm, 6.0%; intramural hematoma, 4.9%; penetrating aortic ulcer, 4.3%; and trauma, 1.7%. The most common cause of reintervention across all aortic diseases was type I endoleak. Other causes for reintervention by aortic disease are listed in the Table. Freedom from reintervention was decreased for TBD compared with other diseases (P < .001; Fig) . Whereas patients requiring in-hospital reinterventions suffered from increased mortality (P ¼ .05), there was no difference in survival in comparing patients undergoing reinterventions with those without (P ¼ .80).
Conclusions: Whereas reinterventions were not rare after TEVAR, there was no difference in mortality between patients undergoing reintervention and those without. Patients undergoing TEVAR for TBD demonstrated the highest reintervention rate. This study highlights the importance of long-term follow-up to address disease-specific patterns of reintervention. Objective: A potential correlation between the indication for low-profile endograft implantation and the incidence of type II endoleaks (T2ELs) after endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms has been postulated. The aim of this study was to report the immediate and midterm incidence and fate of T2ELs in an unselected population of patients treated by EVAR using the Ovation stent graft (Endologix, Irvine, Calif).
Methods: A retrospective study was conducted in three high-volume Italian vascular centers including 261 consecutive elective patients. Outcome measures were intraprocedural, immediate (30-day), 12-month, 
